Oragenicsincis A Biotechnology Company Based In Tampafloridafounded In 1996The Company Focuses On Researching And Developing Nasal Delivery Pharmaceutical Medicationsparticularly In The Fields Of Neurology And Infectious Diseasesoragenics Is Committed To Addressing Infectious Diseasesincluding Coronaviruses And Multidrug Resistant Organisms The Company S Product Pipeline Includes Onp 002A Synthetic Neurosteroid For Treating Mild Traumatic Brain Injuryand Terra Cov 2An Intranasal Vaccine Candidate For Covid 19Additionallyoragenics Is Developing A Novel Class Of Antibiotics Through Its Lantibiotics Programin October 2023The Company Expanded Its Capabilities By Acquiring Assets From Odyssey Healthinc Which Includes Neurological Drug Therapies And A Nasal Delivery System For Various Conditions
No conferences found for this company.
| Company Name | Oragenics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
